Haleos Labs Limited

BSE: 540679 NSE: SMSLIFE
Haleos Labs Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN L74930TG2006PLC050223 Incorporated 31 May 2006 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Listed - NSE: SMSLIFE · BSE: 540679 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹333.79 Cr
▼ 3.17% YoY
EBITDA · FY 2026
₹47.11 Cr
▼ 5.59% YoY
Net profit · FY 2026
₹17.8 Cr
▼ 4.98% YoY
Authorised capital
₹3.5 Cr
Registered with MCA
Paid-up capital
₹3.02 Cr
Issued & subscribed
Open charges
₹103.44 Cr
Satisfied ₹47.83 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
558
Latest available

About Haleos Labs Limited

Data last updated: 06 January 2026

Haleos Labs Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 31 May 2006, the company has been in operation for over 20 years.

Registered with ROC Hyderabad under CIN L74930TG2006PLC050223. Listed on BSE: 540679 and NSE: SMSLIFE.

Capital: an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹3.02 Cr. Formerly known as Potluri Real Estate Private Limtied and Potluri Packaging Industries Private Limited. It is led by directors including Venkata Praveen Talluri and Sundaramma Patibandla.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Hyderabad, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹349.58 Cr, a growth of 13% compared to the previous year.

The company has a workforce of approximately 558 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Sms Lifesciences. As per MCA filings, the company has open charges of ₹103.44 Cr and satisfied charges of ₹47.83 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website smslife.in.

Company Details of Haleos Labs Limited
CIN L74930TG2006PLC050223
Registration Number 050223
Incorporation Date 31 May 2006
ROC Hyderabad
Listing Status Listed (BSE: 540679, NSE: SMSLIFE)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Veeravenkata Satyanarayana Murthy Talluri Managing Director Venkata Praveen Talluri Whole-Time Director Sudeepthi Gopineedi Whole-Time Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    smslife.in
  • Social Media
    **************
  • Registered Address
    Plot No.19 – Iii Road No.71 Jubilee Hills Opp. Bharatiya Vidya Bhavan Public Schoo, L, Hyderabad, Telangana, India – 500096
  • Industry
    Pharma, API Manufacturers
Company report
Haleos Labs Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Haleos Labs Limited report

Financials, compliance, directors, charges, ownership and filings for Haleos Labs Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Haleos Labs Limited

Haleos Labs Limited has undergone 4 name changes throughout its history. The current legal name is Haleos Labs Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Haleos Labs Limited Current
Potluri Real Estate Private Limtied Previous
Potluri Packaging Industries Private Limited Previous
Sms Lifesciences India Private Limited Previous

CIN History of Haleos Labs Limited

Haleos Labs Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74930TG2006PLC050223, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L74930TG2006PLC050223 Current
U74930TG2006PTC050223 Previous
U45201AP2006PTC050223 Previous
U74930AP2006PTC050223 Previous

Associated Brands with Haleos Labs Limited

Haleos Labs Limited operates one associated brand: SMS LifeSciences. These brands represent Haleos Labs Limited's diversified market presence and brand portfolio.

Brand Description Website
SMS LifeSciences
Active Pharmaceutical Ingredients and intermediates are manufactured for pharmaceuticals. smslife.in

Competitors & Alternatives of Haleos Labs Limited

Brands and companies operating in the same space as Haleos Labs Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Haleos Labs Limited

Haleos Labs Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Haleos Labs Limited

Haleos Labs Limited is audited by Rambabu and Co (ICAI peer reviewed, certificate valid till 2027-06-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Rambabu and Co (ICAI peer reviewed, certificate valid till 2027-06-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Haleos Labs Limited

Haleos Labs Limited is currently managed by 10 directors, with 15 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Venkata Praveen Talluri
Also directs: Mahi Drugs Private Limited
Whole-Time Director 21 Aug 2020 5 Years 10 Months Current
Sundaramma Patibandla
Also directs: Isprout Managed Offices Llp, Isprout Developers Llp, Irya Developers Llp and 5 more
Director 12 Feb 2025 1 Years 4 Months Current
Sudeepthi Gopineedi Whole-Time Director 02 Sep 2021 4 Years 10 Months Current
Veeravenkata Satyanarayana Murthy Talluri
Also directs: Mahi Drugs Private Limited
Managing Director 01 Apr 2016 10 Years 3 Months Current
Srinivas Samavedam
Also directs: Hics Academy Of Critical Care Llp, Crest Clinical Services Private Limited
Director 13 Nov 2021 4 Years 7 Months Current
Mannam Malakondaiah
Also directs: Beardsell Limited, Nsl Textiles Limited, Nsl Sez (Hyderabad) Private Limited and 1 more
Director 13 Nov 2021 4 Years 7 Months Current
Showing 6 of 10 current directors. View all directors

Financials of Haleos Labs Limited FY 2026 filings available

Haleos Labs Limited reported revenue of ₹333.79 Cr (down 3.17% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹333.79 Cr ▼ 3.17%
Profit · FY 2026
₹17.8 Cr ▼ 4.98%
EBITDA · FY 2026
₹47.11 Cr ▼ 5.59%
Revenue₹ Cr · Consolidated0200400FY 2020: ₹261 Cr261FY 2020FY 2021: ₹266 Cr · +1.8% YoY266+1.8%FY 2021FY 2022: ₹350 Cr · +31.7% YoY350+31.7%FY 2022FY 2023: ₹316 Cr · -9.8% YoY316-9.8%FY 2023FY 2024: ₹306 Cr · -3% YoY306-3%FY 2024FY 2025: ₹345 Cr · +12.7% YoY345+12.7%FY 2025FY 2026: ₹334 Cr · -3.2% YoY334-3.2%FY 2026
Net Profit₹ Cr · Consolidated0102030FY 2020: ₹10 Cr10.2FY 2020FY 2021: ₹14 Cr · +33.1% YoY13.6+33.1%FY 2021FY 2022: ₹25 Cr · +86.5% YoY25.3+86.5%FY 2022FY 2023: ₹11 Cr · -55% YoY11.4-55%FY 2023FY 2024: ₹6 Cr · -44.4% YoY6.3-44.4%FY 2024FY 2025: ₹19 Cr · +196% YoY18.7+196%FY 2025FY 2026: ₹18 Cr · -5% YoY17.8-5%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year050100Q1'25: ₹93 Cr · +24% YoY92.5+24%Q1'25Q2'25: ₹78 Cr · +13.3% YoY78.5+13.3%Q2'25Q3'25: ₹85 Cr · +17.4% YoY84.6+17.4%Q3'25Q4'25: ₹89 Cr · -1% YoY89.1-1%Q4'25Q1'26: ₹83 Cr · -10.9% YoY82.5-10.9%Q1'26Q2'26: ₹81 Cr · +3.7% YoY81.4+3.7%Q2'26Q3'26: ₹95 Cr · +12% YoY94.8+12%Q3'26Q4'26: ₹75 Cr · -15.7% YoY75.1-15.7%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹333.79 Cr ₹344.72 Cr ₹305.96 Cr ₹315.56 Cr ₹349.74 Cr ₹265.59 Cr ₹260.78 Cr
Other Income ₹2.43 Cr ₹4.86 Cr ₹3.83 Cr ₹3.07 Cr ₹2.07 Cr ₹1.78 Cr ₹2.28 Cr
Total Income ₹336.23 Cr ₹349.58 Cr ₹309.79 Cr ₹318.63 Cr ₹351.81 Cr ₹267.37 Cr ₹263.06 Cr
Cost of Materials Consumed ₹146.69 Cr ₹149.91 Cr ₹150.19 Cr ₹171.33 Cr ₹204.47 Cr ₹135.17 Cr ₹147.04 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹8.18 Cr ₹4.15 Cr ₹97.32 Lakh ₹7.52 Lakh -₹9.79 Cr ₹1.87 Cr ₹10.84 Cr
Employee Benefit Expense ₹65.38 Cr ₹59.54 Cr ₹49.27 Cr ₹43.43 Cr ₹39.9 Cr ₹30.66 Cr ₹26.56 Cr
Finance Costs ₹6.45 Cr ₹8.71 Cr ₹10.16 Cr ₹6.79 Cr ₹6.17 Cr ₹4.53 Cr ₹5.14 Cr
Depreciation & Amortisation ₹15.47 Cr ₹15 Cr ₹14.94 Cr ₹10.79 Cr ₹10.01 Cr ₹7.86 Cr ₹7.86 Cr
Other Expenses ₹85.23 Cr ₹86.09 Cr ₹74.41 Cr ₹71.98 Cr ₹81 Cr ₹67.72 Cr ₹50.95 Cr
Total Expenses ₹311.03 Cr ₹323.39 Cr ₹299.94 Cr ₹304.39 Cr ₹331.77 Cr ₹247.81 Cr ₹248.39 Cr
Profit Before Exceptional Items & Tax ₹25.2 Cr ₹26.19 Cr ₹9.85 Cr ₹14.24 Cr ₹20.04 Cr ₹19.57 Cr ₹14.67 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹2.35 Cr ₹12.69 Cr ₹0 ₹0
Profit Before Tax ₹25.2 Cr ₹26.19 Cr ₹9.85 Cr ₹16.59 Cr ₹32.73 Cr ₹19.57 Cr ₹14.67 Cr
Total Tax Expense ₹7.4 Cr ₹7.46 Cr ₹3.52 Cr ₹5.22 Cr ₹7.43 Cr ₹6.01 Cr ₹4.48 Cr
Net Profit ₹17.8 Cr ₹18.73 Cr ₹6.33 Cr ₹11.38 Cr ₹25.28 Cr ₹13.56 Cr ₹10.18 Cr
  attributable to Owners ₹17.31 Cr ₹20.11 Cr ₹9.09 Cr ₹11.46 Cr - - -
  attributable to NCI ₹48.83 Lakh -₹1.38 Cr -₹2.77 Cr -₹9.57 Lakh - - -
Other Comprehensive Income ₹11.14 Lakh ₹13.09 Lakh -₹45.44 Lakh ₹2.43 Lakh -₹3.59 Lakh -₹7.34 Lakh -₹31.27 Lakh
Total Comprehensive Income ₹17.91 Cr ₹18.86 Cr ₹5.87 Cr ₹11.4 Cr ₹25.24 Cr ₹13.48 Cr ₹9.87 Cr
EBITDA (computed) ₹47.11 Cr ₹49.9 Cr ₹34.94 Cr ₹31.82 Cr ₹36.22 Cr ₹31.96 Cr ₹27.67 Cr
Basic EPS ₹57.26 ₹66.51 ₹30.08 ₹37.92 ₹83.68 ₹44.84 ₹33.68
Diluted EPS ₹57.26 ₹66.51 ₹30.08 ₹37.92 ₹83.68 ₹44.84 ₹33.68
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹454.41 Cr ₹389.99 Cr ₹390.52 Cr ₹394.89 Cr
Non-current Assets ₹291.3 Cr ₹239.42 Cr ₹235.25 Cr ₹235.77 Cr
Current Assets ₹163.11 Cr ₹150.57 Cr ₹155.27 Cr ₹159.12 Cr
Property, Plant & Equipment ₹266.54 Cr ₹230.02 Cr ₹220.89 Cr ₹226.58 Cr
Inventories ₹79.82 Cr ₹67.4 Cr ₹81.21 Cr ₹86.23 Cr
Trade Receivables ₹61.34 Cr ₹68.79 Cr ₹51.35 Cr ₹46.06 Cr
Cash & Equivalents ₹1.21 Cr ₹50.29 Lakh ₹56.95 Lakh ₹1.28 Cr
Equity (Net Worth) ₹229.56 Cr ₹212.05 Cr ₹193.64 Cr ₹188.22 Cr
Equity Share Capital ₹3.02 Cr ₹3.02 Cr ₹3.02 Cr ₹3.02 Cr
Borrowings (Non-current) ₹49.96 Cr ₹18.27 Cr ₹33.15 Cr ₹54.94 Cr
Borrowings (Current) ₹58.89 Cr ₹65.75 Cr ₹64.57 Cr ₹43.7 Cr
Total Debt (computed) ₹108.85 Cr ₹84.01 Cr ₹97.71 Cr ₹98.64 Cr
Current Liabilities ₹156.28 Cr ₹142.07 Cr ₹144.56 Cr ₹133.56 Cr
Total Liabilities ₹224.85 Cr ₹177.94 Cr ₹196.88 Cr ₹206.67 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹37.22 Cr ₹34.06 Cr ₹24.31 Cr ₹14.7 Cr -₹11.24 Cr
Investing Cash Flow -₹57.9 Cr -₹15 Cr -₹18.45 Cr -₹31.29 Cr -₹7.14 Cr
Financing Cash Flow ₹21.38 Cr -₹19.12 Cr -₹6.56 Cr ₹16.89 Cr ₹10.83 Cr
Capital Expenditure ₹57.86 Cr ₹15.35 Cr ₹20.87 Cr ₹48.55 Cr ₹51.15 Cr
Free Cash Flow (computed) -₹20.64 Cr ₹18.71 Cr ₹3.44 Cr -₹33.86 Cr -₹62.39 Cr
Dividends Paid ₹45.35 Lakh ₹45.35 Lakh ₹45.34 Lakh ₹45.35 Lakh ₹45.35 Lakh
Net Change in Cash ₹70.55 Lakh -₹6.65 Lakh -₹70.82 Lakh ₹29.19 Lakh -₹7.55 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹75.14 Cr ₹94.78 Cr ₹81.37 Cr ₹82.5 Cr ₹89.11 Cr ₹84.6 Cr ₹78.46 Cr ₹92.55 Cr ₹89.99 Cr ₹72.05 Cr ₹69.26 Cr ₹74.65 Cr
Other Income ₹2.01 Cr ₹18.34 Lakh ₹42.41 Lakh ₹99.59 Lakh ₹2.34 Cr ₹5.74 Lakh ₹2.04 Cr ₹43.92 Lakh ₹2.36 Cr ₹58.18 Lakh ₹33.59 Lakh ₹61.38 Lakh
Total Income ₹77.15 Cr ₹94.97 Cr ₹81.79 Cr ₹83.5 Cr ₹91.45 Cr ₹84.66 Cr ₹80.5 Cr ₹92.99 Cr ₹92.35 Cr ₹72.64 Cr ₹69.6 Cr ₹75.27 Cr
Cost of Materials Consumed ₹35.86 Cr ₹44.74 Cr ₹39.83 Cr ₹28.41 Cr ₹32.74 Cr ₹39.43 Cr ₹35.01 Cr ₹42.72 Cr ₹33.47 Cr ₹39.19 Cr ₹35.75 Cr ₹41.78 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹4.98 Cr -₹1.12 Cr -₹8.81 Cr ₹6.73 Cr ₹6.63 Cr -₹3.84 Cr ₹76.07 Lakh ₹59.56 Lakh ₹10.32 Cr -₹7.9 Cr -₹3.49 Cr ₹2.05 Cr
Employee Benefit Expense ₹16.17 Cr ₹16.7 Cr ₹16.23 Cr ₹16.29 Cr ₹16.47 Cr ₹14.6 Cr ₹14.09 Cr ₹14.38 Cr ₹12.74 Cr ₹12.56 Cr ₹12.28 Cr ₹11.69 Cr
Finance Costs ₹1.42 Cr ₹1.54 Cr ₹1.62 Cr ₹1.87 Cr ₹2.03 Cr ₹2.14 Cr ₹2.14 Cr ₹2.4 Cr ₹2.84 Cr ₹2.34 Cr ₹2.81 Cr ₹2.18 Cr
Depreciation & Amortisation ₹3.85 Cr ₹3.91 Cr ₹3.89 Cr ₹3.82 Cr ₹3.8 Cr ₹3.76 Cr ₹3.76 Cr ₹3.68 Cr ₹3.78 Cr ₹3.73 Cr ₹3.73 Cr ₹3.7 Cr
Other Expenses ₹23.93 Cr ₹20.42 Cr ₹20.55 Cr ₹19.36 Cr ₹25.85 Cr ₹21.65 Cr ₹20.04 Cr ₹18.57 Cr ₹22.1 Cr ₹18.91 Cr ₹16.86 Cr ₹16.61 Cr
Total Expenses ₹76.25 Cr ₹86.19 Cr ₹73.3 Cr ₹76.48 Cr ₹87.52 Cr ₹77.74 Cr ₹75.8 Cr ₹82.35 Cr ₹85.25 Cr ₹68.82 Cr ₹67.94 Cr ₹77.99 Cr
Profit Before Exceptional Items & Tax ₹90.55 Lakh ₹8.78 Cr ₹8.49 Cr ₹7.02 Cr ₹3.93 Cr ₹6.92 Cr ₹4.7 Cr ₹10.64 Cr ₹7.1 Cr ₹3.81 Cr ₹1.66 Cr -₹2.73 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹90.55 Lakh ₹8.78 Cr ₹8.49 Cr ₹7.02 Cr ₹3.93 Cr ₹6.92 Cr ₹4.7 Cr ₹10.64 Cr ₹7.1 Cr ₹3.81 Cr ₹1.66 Cr -₹2.73 Cr
Total Tax Expense ₹56.15 Lakh ₹2.13 Cr ₹2.07 Cr ₹2.64 Cr ₹44.58 Lakh ₹2.06 Cr ₹1.4 Cr ₹3.54 Cr ₹62.71 Lakh -₹31.28 Lakh ₹2.1 Cr ₹1.1 Cr
Net Profit ₹34.4 Lakh ₹6.65 Cr ₹6.43 Cr ₹4.38 Cr ₹3.48 Cr ₹4.85 Cr ₹3.3 Cr ₹7.1 Cr ₹6.47 Cr ₹4.12 Cr -₹44.25 Lakh -₹3.83 Cr
  attributable to Owners ₹43.57 Lakh ₹6.62 Cr ₹6.1 Cr ₹4.16 Cr ₹2.97 Cr ₹5.47 Cr ₹4.67 Cr ₹7 Cr ₹5.9 Cr ₹4.3 Cr ₹66.63 Lakh -₹1.8 Cr
  attributable to NCI -₹9.17 Lakh ₹3.21 Lakh ₹32.27 Lakh ₹22.52 Lakh ₹50.99 Lakh -₹61.24 Lakh -₹1.37 Cr ₹9.82 Lakh ₹57.07 Lakh -₹18.07 Lakh -₹1.11 Cr -₹2.03 Cr
Other Comprehensive Income ₹4.5 Lakh ₹4.27 Lakh ₹3.92 Lakh ₹3.6 Lakh ₹54.03 Lakh -₹14.81 Lakh -₹13.64 Lakh -₹12.5 Lakh -₹47.45 Lakh ₹73,000 ₹67,000 ₹61,000
Total Comprehensive Income ₹38.9 Lakh ₹6.69 Cr ₹6.46 Cr ₹4.42 Cr ₹4.02 Cr ₹4.71 Cr ₹3.16 Cr ₹6.97 Cr ₹6 Cr ₹4.13 Cr -₹43.58 Lakh -₹3.82 Cr
EBITDA (computed) ₹6.17 Cr ₹14.23 Cr ₹13.99 Cr ₹12.71 Cr ₹9.76 Cr ₹12.81 Cr ₹10.6 Cr ₹16.72 Cr ₹13.72 Cr ₹9.87 Cr ₹8.2 Cr ₹3.14 Cr
Basic EPS ₹1.44 ₹21.89 ₹20.19 ₹13.75 ₹9.83 ₹18.08 ₹15.46 ₹23.15 ₹19.53 ₹14.24 ₹2.20 ₹-5.94
Diluted EPS ₹1.44 ₹21.89 ₹20.19 ₹13.75 ₹9.83 ₹18.08 ₹15.46 ₹23.15 ₹19.53 ₹14.24 ₹2.20 ₹-5.94
Latest 12 quarters shown of 25 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹300.99 Cr ₹333.37 Cr ₹300 Cr ₹315.24 Cr ₹345.63 Cr ₹260.26 Cr ₹256.92 Cr
Other Income ₹1.42 Cr ₹3.95 Cr ₹3.84 Cr ₹2.88 Cr ₹1.54 Cr ₹1.33 Cr ₹1.88 Cr
Total Income ₹302.41 Cr ₹337.32 Cr ₹303.84 Cr ₹318.12 Cr ₹347.16 Cr ₹261.59 Cr ₹258.81 Cr
Cost of Materials Consumed ₹145.57 Cr ₹164.43 Cr ₹161.19 Cr ₹189.95 Cr ₹216.16 Cr ₹137.76 Cr ₹155.75 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹6.51 Cr ₹4.69 Cr ₹97.57 Lakh ₹30.1 Lakh -₹7.79 Cr ₹1.9 Cr ₹6.29 Cr
Employee Benefit Expense ₹49.39 Cr ₹45.78 Cr ₹37.94 Cr ₹34.72 Cr ₹32.51 Cr ₹27.11 Cr ₹23.27 Cr
Finance Costs ₹6.03 Cr ₹7.88 Cr ₹8.9 Cr ₹5.09 Cr ₹4.63 Cr ₹4.5 Cr ₹5.09 Cr
Depreciation & Amortisation ₹10.66 Cr ₹10.26 Cr ₹10.25 Cr ₹8.17 Cr ₹7.99 Cr ₹7.21 Cr ₹7.24 Cr
Other Expenses ₹72.06 Cr ₹74.24 Cr ₹65.47 Cr ₹63.86 Cr ₹73.37 Cr ₹63.75 Cr ₹47.82 Cr
Total Expenses ₹277.22 Cr ₹307.28 Cr ₹284.73 Cr ₹302.1 Cr ₹326.88 Cr ₹242.23 Cr ₹245.47 Cr
Profit Before Exceptional Items & Tax ₹25.19 Cr ₹30.04 Cr ₹19.11 Cr ₹16.02 Cr ₹20.28 Cr ₹19.35 Cr ₹13.34 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹2.35 Cr ₹12.69 Cr ₹0 ₹0
Profit Before Tax ₹25.19 Cr ₹30.04 Cr ₹19.11 Cr ₹18.37 Cr ₹32.98 Cr ₹19.35 Cr ₹13.34 Cr
Total Tax Expense ₹7.41 Cr ₹8.67 Cr ₹6.05 Cr ₹5.15 Cr ₹7.6 Cr ₹6.19 Cr ₹4.19 Cr
Net Profit ₹17.78 Cr ₹21.37 Cr ₹13.07 Cr ₹13.22 Cr ₹25.38 Cr ₹13.17 Cr ₹9.15 Cr
Other Comprehensive Income ₹7.81 Lakh ₹3.01 Lakh -₹41.19 Lakh ₹4.99 Lakh -₹5.04 Lakh -₹8.75 Lakh -₹32.35 Lakh
Total Comprehensive Income ₹17.85 Cr ₹21.4 Cr ₹12.65 Cr ₹13.27 Cr ₹25.33 Cr ₹13.08 Cr ₹8.82 Cr
EBITDA (computed) ₹41.89 Cr ₹48.18 Cr ₹38.27 Cr ₹29.29 Cr ₹32.9 Cr ₹31.07 Cr ₹25.67 Cr
Basic EPS ₹58.80 ₹70.69 ₹43.22 ₹43.72 ₹83.95 ₹43.56 ₹30.26
Diluted EPS ₹58.80 ₹70.69 ₹43.22 ₹43.72 ₹83.95 ₹43.56 ₹30.26
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹403.34 Cr ₹358.31 Cr ₹347.38 Cr ₹337.39 Cr
Non-current Assets ₹221.63 Cr ₹180.52 Cr ₹172.88 Cr ₹169.8 Cr
Current Assets ₹181.71 Cr ₹177.79 Cr ₹174.49 Cr ₹167.59 Cr
Property, Plant & Equipment ₹188.61 Cr ₹148.41 Cr ₹135.78 Cr ₹137.83 Cr
Inventories ₹69.81 Cr ₹60.58 Cr ₹74.59 Cr ₹80.46 Cr
Trade Receivables ₹54.26 Cr ₹64.53 Cr ₹49.35 Cr ₹45.52 Cr
Cash & Equivalents ₹39.89 Lakh ₹40.13 Lakh ₹33.49 Lakh ₹15.14 Lakh
Equity (Net Worth) ₹214.58 Cr ₹197.18 Cr ₹176.23 Cr ₹164.03 Cr
Equity Share Capital ₹3.02 Cr ₹3.02 Cr ₹3.02 Cr ₹3.02 Cr
Borrowings (Non-current) ₹35.18 Cr ₹17.31 Cr ₹28.31 Cr ₹45.97 Cr
Borrowings (Current) ₹57.93 Cr ₹61.86 Cr ₹60.41 Cr ₹39.17 Cr
Total Debt (computed) ₹93.11 Cr ₹79.17 Cr ₹88.73 Cr ₹85.14 Cr
Current Liabilities ₹133.02 Cr ₹124.3 Cr ₹122.7 Cr ₹110.57 Cr
Total Liabilities ₹188.76 Cr ₹161.14 Cr ₹171.15 Cr ₹173.36 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹38.43 Cr ₹28.03 Cr ₹14.75 Cr ₹1.88 Cr -₹14.66 Cr
Investing Cash Flow -₹49.28 Cr -₹13.77 Cr -₹13.75 Cr -₹27.96 Cr -₹7.49 Cr
Financing Cash Flow ₹10.85 Cr -₹14.2 Cr -₹81.83 Lakh ₹25.29 Cr ₹14.63 Cr
Capital Expenditure ₹49.24 Cr ₹14.09 Cr ₹13.72 Cr ₹33.91 Cr ₹24.96 Cr
Free Cash Flow (computed) -₹10.81 Cr ₹13.95 Cr ₹1.03 Cr -₹32.03 Cr -₹39.62 Cr
Dividends Paid ₹45.35 Lakh ₹45.35 Lakh ₹45.34 Lakh ₹45.35 Lakh ₹45.35 Lakh
Net Change in Cash -₹24,000 ₹6.64 Lakh ₹18.36 Lakh -₹79.5 Lakh -₹7.52 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹63.38 Cr ₹80.72 Cr ₹77.84 Cr ₹79.04 Cr ₹85.43 Cr ₹82.88 Cr ₹78.5 Cr ₹86.57 Cr ₹86.37 Cr ₹71.23 Cr ₹67.84 Cr ₹74.56 Cr
Other Income ₹96.92 Lakh ₹7.84 Lakh ₹43.64 Lakh ₹1.01 Cr ₹2.2 Cr ₹6.13 Lakh ₹1.26 Cr ₹42.98 Lakh ₹2.28 Cr ₹64.04 Lakh ₹33.47 Lakh ₹58.3 Lakh
Total Income ₹64.35 Cr ₹80.8 Cr ₹78.28 Cr ₹80.05 Cr ₹87.63 Cr ₹82.94 Cr ₹79.75 Cr ₹87 Cr ₹88.65 Cr ₹71.87 Cr ₹68.18 Cr ₹75.14 Cr
Cost of Materials Consumed ₹33.02 Cr ₹39.36 Cr ₹41.6 Cr ₹33.64 Cr ₹38.95 Cr ₹43.14 Cr ₹37.6 Cr ₹44.75 Cr ₹37.51 Cr ₹42.71 Cr ₹37.25 Cr ₹43.73 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹7.34 Cr -₹21.45 Lakh -₹4.36 Cr ₹5.4 Cr ₹5.86 Cr -₹3.31 Cr ₹1.26 Cr ₹88.04 Lakh ₹10.21 Cr -₹6.97 Cr -₹3.62 Cr ₹1.35 Cr
Employee Benefit Expense ₹12.06 Cr ₹12.46 Cr ₹12.38 Cr ₹12.5 Cr ₹12.46 Cr ₹11.24 Cr ₹10.9 Cr ₹11.18 Cr ₹9.55 Cr ₹9.7 Cr ₹9.57 Cr ₹9.13 Cr
Finance Costs ₹1.34 Cr ₹1.46 Cr ₹1.51 Cr ₹1.73 Cr ₹1.84 Cr ₹1.96 Cr ₹1.92 Cr ₹2.16 Cr ₹2.56 Cr ₹2.04 Cr ₹2.48 Cr ₹1.82 Cr
Depreciation & Amortisation ₹2.66 Cr ₹2.69 Cr ₹2.68 Cr ₹2.63 Cr ₹2.62 Cr ₹2.56 Cr ₹2.57 Cr ₹2.5 Cr ₹2.62 Cr ₹2.55 Cr ₹2.55 Cr ₹2.53 Cr
Other Expenses ₹19.44 Cr ₹17.56 Cr ₹17.43 Cr ₹16.67 Cr ₹22.57 Cr ₹18.73 Cr ₹16.94 Cr ₹16 Cr ₹18.3 Cr ₹16.77 Cr ₹15.17 Cr ₹15.23 Cr
Total Expenses ₹61.18 Cr ₹73.31 Cr ₹71.23 Cr ₹72.57 Cr ₹84.29 Cr ₹74.33 Cr ₹71.19 Cr ₹77.46 Cr ₹80.74 Cr ₹66.8 Cr ₹63.4 Cr ₹73.78 Cr
Profit Before Exceptional Items & Tax ₹3.18 Cr ₹7.49 Cr ₹7.05 Cr ₹7.48 Cr ₹3.33 Cr ₹8.61 Cr ₹8.56 Cr ₹9.54 Cr ₹7.91 Cr ₹5.07 Cr ₹4.77 Cr ₹1.36 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹3.18 Cr ₹7.49 Cr ₹7.05 Cr ₹7.48 Cr ₹3.33 Cr ₹8.61 Cr ₹8.56 Cr ₹9.54 Cr ₹7.91 Cr ₹5.07 Cr ₹4.77 Cr ₹1.36 Cr
Total Tax Expense ₹94.3 Lakh ₹2.08 Cr ₹2.07 Cr ₹2.32 Cr ₹65.9 Lakh ₹2.38 Cr ₹2.55 Cr ₹3.08 Cr ₹1.97 Cr ₹1.76 Cr ₹1.66 Cr ₹65.76 Lakh
Net Profit ₹2.23 Cr ₹5.41 Cr ₹4.98 Cr ₹5.16 Cr ₹2.68 Cr ₹6.23 Cr ₹6.01 Cr ₹6.46 Cr ₹5.93 Cr ₹3.31 Cr ₹3.12 Cr ₹70.05 Lakh
Other Comprehensive Income ₹5.21 Lakh ₹91,000 ₹87,000 ₹83,000 ₹40.08 Lakh -₹13.39 Lakh -₹12.36 Lakh -₹11.33 Lakh -₹45.32 Lakh ₹1.51 Lakh ₹1.37 Lakh ₹1.25 Lakh
Total Comprehensive Income ₹2.29 Cr ₹5.42 Cr ₹4.99 Cr ₹5.17 Cr ₹3.08 Cr ₹6.09 Cr ₹5.88 Cr ₹6.35 Cr ₹5.48 Cr ₹3.33 Cr ₹3.13 Cr ₹71.3 Lakh
EBITDA (computed) ₹7.17 Cr ₹11.64 Cr ₹11.24 Cr ₹11.85 Cr ₹7.8 Cr ₹13.13 Cr ₹13.06 Cr ₹14.2 Cr ₹13.09 Cr ₹9.66 Cr ₹9.81 Cr ₹5.71 Cr
Basic EPS ₹7.39 ₹17.88 ₹16.46 ₹17.06 ₹8.85 ₹20.60 ₹19.87 ₹21.37 ₹19.63 ₹10.96 ₹10.31 ₹2.32
Diluted EPS ₹7.39 ₹17.88 ₹16.46 ₹17.06 ₹8.85 ₹20.60 ₹19.87 ₹21.37 ₹19.63 ₹10.96 ₹10.31 ₹2.32
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Haleos Labs Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Haleos Labs Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 72.11%, domestic institutional investors hold 0.30%, retail and other public shareholders hold 27.60% of Haleos Labs Limited. The company had 6,937 shareholders on record.

Promoters: 72.11%DII (Domestic Institutional): 0.30%Retail & Others: 27.60%
Mar 2026
QUARTER
72.11% Promoters
0.30% DII (Domestic Institutional)
27.60% Retail & Others
Promoter holding - history
Now 72.11% · Mar 2026High 72.11% · Mar 2026Low 67.69% · Dec 2021
66%68%70%72%74%Aug 2017Jun 2019Jun 2021Jun 2023Jun 2025Aug 2017: 67.99%Sep 2017: 67.99%Dec 2017: 67.99%Mar 2018: 67.99%Jun 2018: 67.99%Sep 2018: 67.99%Dec 2018: 67.99%Mar 2019: 67.99%Jun 2019: 67.99%Sep 2019: 67.99%Dec 2019: 67.99%Mar 2020: 68.00%Jun 2020: 68.00%Sep 2020: 68.24%Dec 2020: 68.26%Mar 2021: 68.26%Jun 2021: 67.74%Sep 2021: 67.74%Dec 2021: 67.69%Mar 2022: 68.96%Jun 2022: 69.85%Sep 2022: 69.86%Dec 2022: 70.32%Mar 2023: 70.32%Jun 2023: 70.32%Sep 2023: 70.32%Dec 2023: 70.68%Mar 2024: 71.19%Jun 2024: 71.41%Sep 2024: 71.41%Dec 2024: 71.41%Mar 2025: 71.41%Jun 2025: 71.41%Sep 2025: 71.41%Dec 2025: 71.80%Mar 2026: 72.11%67.69%72.11%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters72.11%71.80%71.41%71.41%71.41%71.41%
Public27.89%28.20%28.59%28.59%28.59%28.59%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Promoters72.11%71.41%71.19%70.32%68.96%68.26%68.00%67.99%67.99%
Public27.89%28.59%28.81%29.68%31.04%31.74%32.00%32.01%32.01%
Promoter change (YoY, %pts)+0.70+0.22+0.87+1.36+0.70+0.26+0.01+0.00-

Board & Governance of Haleos Labs Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Haleos Labs Limited has 7 directors - 4 independent and 3 executive. The board is chaired by VEERA VENKATA SATYANARAYANA MURTHY TALLURI.

DirectorPositionOn board sinceListed boards
VEERA VENKATA SATYANARAYANA MURTHY TALLURI Executive Director · MD · Chairperson 2016-04-01 1
SARATH KUMAR PAKALAPATI Non-Executive - Independent Director 2017-05-25 1
VENKATA PRAVEEN TALLURI Executive Director 2020-08-21 1
SUDEEPTHI GOPINEEDI Executive Director 2021-09-02 1
MANNAM MALAKONDAIAH Non-Executive - Independent Director 2021-11-13 2
SRINIVAS SAMAVEDAM Non-Executive - Independent Director 2021-11-13 1
SUNDARAMMA PATIBANDLA Non-Executive - Independent Director 2025-02-12 1
Board Committees
CommitteeMembers
Audit Committee SARATH KUMAR PAKALAPATI (Chairperson), MANNAM MALAKONDAIAH, VEERA VENKATA SATYANARAYANA MURTHY TALLURI, SUNDARAMMA PATIBANDLA
Nomination and remuneration committee MANNAM MALAKONDAIAH (Chairperson), SARATH KUMAR PAKALAPATI, SRINIVAS SAMAVEDAM, SUNDARAMMA PATIBANDLA
Stakeholders Relationship Committee SARATH KUMAR PAKALAPATI (Chairperson), VEERA VENKATA SATYANARAYANA MURTHY TALLURI, SUNDARAMMA PATIBANDLA
Corporate Social Responsibility Committee VEERA VENKATA SATYANARAYANA MURTHY TALLURI (Chairperson), VENKATA PRAVEEN TALLURI, MANNAM MALAKONDAIAH, SRINIVAS SAMAVEDAM

Group Structure of Haleos Labs Limited

Haleos Labs Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Haleos Labs Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Mahi Drugs Private Limited U24233AP2012PTC084875 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Haleos Labs Limited

Open charges
₹103.44 Cr
Satisfied charges
₹47.83 Cr
Breakdown by lending institutions
Others₹53.44 Cr
Hdfc Bank Limited₹50.00 Cr
Latest charge details
DateLenderAmountStatus
12 Aug 2022 Hdfc Bank Limited ₹30 Cr Open
31 Mar 2022 Hdfc Bank Limited ₹20 Cr Open
29 Mar 2022 Others ₹3.44 Cr Open
25 Sep 2018 Others ₹20 Cr Open
26 May 2017 Others ₹30 Cr Open

Total charge records: 8 View all charges

Employees and EPFO Compliance at Haleos Labs Limited

Haleos Labs Limited has a workforce of 558 employees as of Mar 22, 2024.

Employee count
558
Active EPFO establishments
3
Employee growth
-0.71%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Haleos Labs Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Haleos Labs Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Haleos Labs Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Haleos Labs Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Haleos Labs Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Haleos Labs Limited

MSME Payment Delays by Haleos Labs Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Haleos Labs Limited

Subsidiaries & Group Companies of Haleos Labs Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Haleos Labs Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Haleos Labs Limited

MCA Filings & Documents of Haleos Labs Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Haleos Labs Limited

Activity
30 Sep 2025
Haleos Labs Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
20 Aug 2025
A charge registered on 16 Mar 2021 via Charge ID 100425999 with Others was fully satisfied on 20 Aug 2025.
Activity
31 Mar 2025
Haleos Labs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
12 Feb 2025
Sundaramma Patibandla was appointed as a Director on 12 Feb 2025 & has been associated with this company since 1 year 4 months.
Charges
05 Mar 2024
A charge with Others of Rs. 30.00 Cr registered on 26 May 2017 with Charge ID 100100545 was modified on 05 Mar 2024.
Charges
23 Feb 2024
A charge with Hdfc Bank Limited of Rs. 20.00 Cr registered on 31 Mar 2022 with Charge ID 100571180 was modified on 23 Feb 2024.

Recent News on Haleos Labs Limited

Frequently Asked Questions about Haleos Labs Limited

Haleos Labs Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 31 May 2006 (20+ years old) and is registered under CIN L74930TG2006PLC050223. Listed on BSE: 540679 and NSE: SMSLIFE. The company has 558 employees.

Haleos Labs Limited reported revenue of ₹349.58 Cr for FY 2025 (up 13.00% YoY).

The current directors of Haleos Labs Limited are:

The primary industry of Haleos Labs Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes. Haleos Labs Limited is listed on both BSE (code: 540679) and NSE (symbol: SMSLIFE).

Haleos Labs Limited can be reached at the registered office: Plot No.19 – Iii Road No.71 Jubilee Hills Opp. Bharatiya Vidya Bhavan Public Schoo, L, Hyderabad, Telangana, India – 500096, or through the website smslife.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available